PRESS / MEDIA KIT

Please feel free to contact us at event@accelsiors.com in case you are interested in getting more information.

LOGO OF THE FORUM


Download:
LOGO-transparent-background
(.PNG, 28,7 KB)

Download:
LOGO-white-background
(.JPG, 53,1 KB)

 

PRESS RELEASES

LEAFLET / PHOTO / VIDEO


Download:
Leaflet_2nd-Biosimilars-Forum
(.PDF, 1,09 MB)
Download:
Pictures_1st-Biosimilars-Forum
(.ZIP, 29,8 MB)

Aftermovie:
1st Annual Biosimilars Forum
(Youtube, 16:34 Min.)

ABOUT THE ORGANIZERS

The Annual Biosimilars Forum event series was founded in 2016 by two prestigious Central European scientific societies, the Viennese Section of the IBS and the Hungarian Society for Clinical Biostatistics in cooperation with the Accelsiors CRO Ltd., aimed at increasing effectiveness of clinical research and in order to provide even more effective support in sharing of recent scientific and practical knowledge for biosimilar development professionals and provide an opportunity for a constructive and open dialogue between regulatory professionals, clinical researchers, medical statisticians and pharmaceutical developers.

Viennese Section of the International Biometric Society
The Viennese Section of the International Biometric Society is part of the ROeS, the Austrian Swiss Region of the International Biometric Society (IBS). WBS is an independent, non-profit organization which provides a professional forum for discussions of how to apply statistical methods in biological and medical science.

Hungarian Society for Clinical Biostatistics
The Hungarian Society for Clinical Biostatistics is a national group of International Society for Clinical Biostatistics (ISCB), and it was founded to stimulate research into the principles and methodology used in the design and analysis of clinical research and to increase the relevance of statistical theory to the real world of clinical medicine.

Acccelsiors CRO Ltd.
Accelsiors – as a scientific driven CRO – has been a committed supporter of biosimilar drug development, many of their professionals were involved into biosimilar drug development from the early beginnings, guided and managed the first biosimilar drug development projects and professionally supporting clinical trials as well as registration in this innovative field and being active in the clinical research arena in the past two decades.